Assessing Cognitive Decline at Home

Launched by STANFORD UNIVERSITY · Nov 21, 2024

Keywords

ClinConnect Summary

This clinical trial, titled "Assessing Cognitive Decline at Home," is focused on understanding and tracking the mental and emotional challenges faced by older adults with mild cognitive impairment or dementia, including Alzheimer's disease. The researchers aim to find better ways to monitor these symptoms in the comfort of patients' homes using sensors that can observe daily activities. By collecting this information, they hope to create a system that helps doctors see patterns in patients' behaviors and feelings, which can lead to more accurate diagnoses and better management of their mental health.

To participate in this study, individuals must be 65 years or older and either have mild to moderate dementia or be at risk for it. It's also important that they have a study partner who can check in with them at least once a week. However, those with severe mobility issues or who live in care facilities are not eligible. Participants can expect to have their daily activities monitored through sensors, and their caregivers will fill out questionnaires about their symptoms. This information will help develop a useful tool for doctors to better understand and support their patients' needs.

Gender

ALL

Eligibility criteria

• Inclusion criteria:
• • Age 65+ years old
• • Any age and ethnicity.
• • With or without, or at risk of mild to moderate dementia and healthy controls.
• • Availability of a study partner (informant) who has contact with the patient at least once a week (this can also be the surrogate/LAR but does not necessarily have to be)
• Exclusion criteria:
• • Those with severe mobility impairments
• • participants in non-home settings (skilled nursing facilities, etc.).